Last updated Nov 17, 2026. 19 unique records for (livagen). 2026 is a partial year. The named-compound corpus is small (19 unique records) and is narrowly sourced: a large share comes from a single short-peptide bioregulator research tradition. This page does not treat that corpus as broadly independently replicated. Source on PubMed
RC-LIV · Longevity Research
RC-LIV
Longevity Research
Vial sizes for laboratory supply, not a protocol.
Key specifications
Catalog facts are taken from the live PEPTIDEA™ listing. Formula and molecular weight are from PubChem. Sequence is omitted here.
- Catalog title
- RC-LIV | Longevity Research
- Research focus
- Longevity Research
- Also described as
- Livagen · KEDA tetrapeptide (Lys-Glu-Asp-Ala)
- Format
- Lyophilized research peptide
- Catalog status
- In stock (public listing)
- Presentations
- 20 mg vialCatalog sizes, not a protocol
- Molecular formula
- C18H31N5O9PubChem CID 87919683
- Molecular weight
- 461.5PubChem average for CID 87919683
- Receptor context
- Described in the literature as a short synthetic tetrapeptide (Lys-Glu-Asp-Ala)PubChem and published identity literature; research context only
- Sequence
- Not reproduced hereSee primary literature / PubChem
- Researcher access
- Sign-in required to view pricing
- PubMed records
- 19 uniqueQuery above, Nov 17, 2026
Catalog notes & use limitations
Research-catalog framing only. This section does not describe effects in people or study outcomes.
Catalog notes
Listed under Longevity Research
RC-LIV appears in the PEPTIDEA™ Longevity and Cellular Lifecycle Research collection with RC-EPI and RC-GLTA.
Narrowly sourced literature
Almost all of the named-compound records come from a single short-peptide bioregulator research tradition. This page states that limitation and does not treat the corpus as broadly replicated.
20 mg vial
The catalog presentation is a 20 mg vial. That is a presentation of the research material, not a protocol.
Use limitations
Research use only
Not for human or veterinary use. Not a drug, not a cosmetic, and not medical advice. Not presented here as a treatment or weight-management product.
No outcome or dosing information
This page does not list administration amounts, schedules, or clinical results. Catalog vial sizes are presentations of the research material, not a protocol.
Confirm details from primary sources
Formula and molecular weight are cited from PubChem when a single compound applies; otherwise see the catalog notes. Sequence is omitted. Read the original papers for laboratory context — results stay in the original publications.
Specifications
Laboratory-catalog and public-chemistry details. Items without a cited source are marked.
| Catalog title | RC-LIV | Longevity Research |
|---|---|
| Category | Longevity Research (Longevity and Cellular Lifecycle Research) |
| Associated names | Livagen; tetrapeptide Lys-Glu-Asp-Ala (KEDA) |
| Format | Lyophilized research peptide |
| Public catalog status | In stock (as of Nov 17, 2026) |
| Catalog presentations | 20 mg vial — sizes of the research material, not a use protocol |
| Molecular formula | C18H31N5O9 (PubChem CID 87919683, retrieved Nov 17, 2026) |
| Molecular weight | 461.5 (PubChem average for CID 87919683) |
| InChIKey | IKVDKWACACMDLR-BJDJZHNGSA-N (PubChem) |
| Receptor context | Published papers from a narrowly sourced short-peptide bioregulator tradition describe Livagen as the tetrapeptide Lys-Glu-Asp-Ala (KEDA). That is an identity description, not a use claim, and it is not evidence of broad independent replication. |
| Sequence | Not reproduced on this page. See primary literature and the PubChem record. |
| Pricing | Visible after researcher sign-in |
Research literature
These are Peptidea-written summaries of selected publications, prepared so you can stay on peptidea.net. Each card describes what was studied — the research question, study type, and mechanism or setting. We do not restate results, endpoints, or protocols. Full papers remain with their publishers; a small PubMed source link is included only for citation.
Khavinson et al.
This paper examined Livagen in laboratory studies of chromatin in lymphocytes obtained from older donors. It is included as named-compound experimental literature. The donor description is a statement about the experimental material, not a use claim, and a large share of this literature comes from a single research tradition.
Chromatin-activation findings and any aging-application wording in the paper are not restated on this page.
Riadnova et al.
This paper examined the peptide Livagen in an organotypic liver-culture model. It is a laboratory morphology study, not a clinical trial, and it belongs to the same narrowly sourced research tradition.
Morphological findings in the paper are not reproduced here.
Timofeeva et al.
This paper studied Livagen and digestive-enzyme activity in rats of different ages, including both gastrointestinal and other tissues. It is an animal laboratory study, not a study of this catalog vial in people.
Enzyme-activity measurements and any age-comparison findings in the paper are not restated on this page.
Kost et al.
This paper examined the peptides Livagen and Epitalon in a laboratory study of enkephalin-degrading enzymes in human serum. It is included as named-compound biochemical literature from the same research tradition, not as a clinical use study.
Enzyme findings in the paper are not reproduced here.
Original titles are omitted or neutralized when they use clinical-outcome wording. Counts and the optional source links use the query (livagen). Source on PubMed
Storage & handling
General laboratory-catalog guidance for layout purposes. Always follow the vial label and your institution’s written procedures.
- Handle as a lyophilized research material intended for laboratory use only.
- Store according to the conditions printed on the label and in any compound document provided to approved researchers.
- Protect closed vials from moisture and unnecessary temperature swings.
- If reconstitution is performed, use only the laboratory’s own written procedures. This page does not provide volumes, solvents, or working concentrations.
- This material is not for human or veterinary use and is not medical advice.
Research Use Only. Not for human or veterinary use. Not medical advice. PEPTIDEA™ is a trademark of Grey Bug LLC.




